참고문헌
- Agoff SN, Brentnall TA, Crispin DA, Taylor SL, Raaka S, Haggitt RC, Reed MW, Afonina IA, Rabinovitch PS, Stevens AC, Feng Z, Bronner MP. The role of cyclooxygenase 2 in ulcerative colitis-associated neoplasia. Am J Pathol. 2000. 157: 737-745. https://doi.org/10.1016/S0002-9440(10)64587-7
- Bouma G, Strober W. The immunological and genetic basis of inflammatory bowel disease. Nat Rev Immunol. 2003. 3: 521-533. https://doi.org/10.1038/nri1132
- Brune K, Hinz B. "Selective cyclooxygenase-2 inhibitors: similarities and differences". Scand J Rheumatol. 2004. 33: 1-6.
- Camuesco D, Galvez J, Nieto A, Comalada M, Rodriiguez-Cabezas ME, Concha A, Xaus J, Zarzuelo A. Dietary olive oil supplemented with fish oil, rich in EPA and DHA (n-3)polyunsaturated fatty acids, attenuates colonic inflammation in rats with DSS-induced colitis. J Nutr. 2005. 135: 687-694. https://doi.org/10.1093/jn/135.4.687
- Cuong TD, Hung TM, Lee MK, Thao NTP, Jang HS, Min BS. Cytotoxic compounds from the roots of Pulsatilla koreana. Nat Prod Sci. 2009. 15: 250-255.
- El-Medany A, Mahgoub A, Mustafa A, Arafa M, Morsi M. "The effects of selective cyclooxygenase-2 inhibitors, celecoxib and rofecoxib, on experimental colitis induced by acetic acid in rats". Gut. 2003. 52: 1714-1720. https://doi.org/10.1136/gut.52.12.1714
- Hendrickson BA, Gokhale R, Cho JH. Clinical aspects and Pathophysiology of inflammatory bowel disease. Clin Microbiol Rev. 2002. 15: 79-94. https://doi.org/10.1128/CMR.15.1.79-94.2002
-
Ishiguro K, Ando T, Maeda O, Hasegawa M, Kadomatsu K, Ohmiya N, Niwa Y, Xavier R, Goto H. Paeonolattenuates TNBS-induced colitis by inhibiting NF-
${\kappa}B$ and STAT1 transactivation. Toxicol Appl Pharmacol. 2006. 217: 35-42. https://doi.org/10.1016/j.taap.2006.07.002 -
Jobin C, Sartor RB. The I
${\kappa}B$ /NF-${\kappa}B$ system: a key determinant of mucosal inflammation and protection. Am J Physiol Cell Physiol. 2000. 278: C451-C462. https://doi.org/10.1152/ajpcell.2000.278.3.C451 - Kim Y, Bang SC, Lee JH, Ahn BZ. Pulsatilla saponin D: The antitumor principle from Pulsatilla koreana. Arch Pharm Res. 2004. 27: 915-918. https://doi.org/10.1007/BF02975843
- Lin TY, Liu YC, Jheng JR, Tsai HP, Jan JT, Wong WR, Horng JT. Anti-enterovirus 71 activity screening of Chinese herbs with anti-infection and inflammation activities. Am J Chin Med. 2009. 37: 143-158. https://doi.org/10.1142/S0192415X09006734
- Lee TH, Huang NK, Lai TC, Yang AT, Wang GJ. Anemonin, from Clematis crassifolia, potent and selective inducible nitric oxide synthase inhibitor. J Ethnopharmacol. 2008. 28: 518-527.
-
Ma TY, Iwamoto Akotia V, Pedram A, Boivin MA, Said HM. TNF-
${\alpha}$ -induced increase in intestinal epithelial tight junction permeability requires NF-${\kappa}B$ activation. Am J Physiol Gastrointest Liver Physiol. 2004. 286: G367-G376. https://doi.org/10.1152/ajpgi.00173.2003 - Martin ML, San Roman L, Dominguez A. In vitro activity of protoanemonin, an antifungal agent. Planta Med. 1990. 56: 66-69. https://doi.org/10.1055/s-2006-960886
- Montrose DC, Nakanishi M, Murphy RC, Zarini S, McAleer JP, Vella AT, Rosenberg DW. The role of PGE2 in intestinal inflammation and tumorigenesis. Prostaglandins Other Lipid Mediat. 2015. 117: 26-36.
- Morita I. Distinct functions of COX-1 and COX-2. Prostaglandins Other Lipid Mediat. 2002. 68-69: 165-175. https://doi.org/10.1016/S0090-6980(02)00029-1
- Murthy SN, Cooper HS, Shim H, Shah RS, Ibarahim SA, Sedergran DJ. Treatment of dextran sulfate sodium-induced murine colitis by intracolonic cyclosporin. Dig Dis Sci. 1993. 38: 1722-1734. https://doi.org/10.1007/BF01303184
- Papadakis KA, Targan SR. Role of cytokines in the pathogenesis of inflammatory bowel disease. Annu Rev Med. 2000. 51: 289-298. https://doi.org/10.1146/annurev.med.51.1.289
-
Puangpraphant S, Dia VP, de Mejia EG, Garcia G, Berhow MA, Wallig MA. Yerba mate tea and mate saponins prevented azoxymethane-induced inflammation of rat colon through suppression of NF-
${\kappa}B$ p65ser(311) signaling via$I{\kappa}B-{\alpha}$ and GSK-$3{\beta}$ reduced phosphorylation. Biofactors. 2013. 39: 430-440. https://doi.org/10.1002/biof.1083 - Ramakers JD, Verstege MI, Thuijls G, Te Velde AA, Mensink RP, Plat J. The PPARgamma agonist rosiglitazone impairs colonic inflammation in mice with experimental colitis. J Clin Immunol. 2007. 27: 275-283. https://doi.org/10.1007/s10875-007-9074-2
- Sandborn WJ, Targan SR. Biologic therapy of inflammatory bowel disease. Gastroenterology. 2002. 122: 1592-1608. https://doi.org/10.1053/gast.2002.33426
- Talero E, Sanchez-Fidalgo S, Villegas I, de la Lastra CA, Illanes M, Motilva V. Role of different inflammatory and tumor biomarkers in the development of ulcerative colitis-associated carcinogenesis. Inflamm Bowel Dis. 2011. 17: 696-710. https://doi.org/10.1002/ibd.21420
- Talhouk RS, Karam C, Fostok S, El-Jouni W, Barbour EK. Antiinflammatory bioactivities in plant extracts. J Med Food. 2007. 10: 1-10. https://doi.org/10.1089/jmf.2005.055
- Yang HJ, Cho YW, Kim SH, Kim YC, Sung SH. Triterpenoidal saponins of Pulsatilla koreana roots. Phytochemistry. 2010. 71: 1892-1899. https://doi.org/10.1016/j.phytochem.2010.07.013
- Yang SK. Current status and clinical characteristics of inflammatory bowel disease in Korea. Korean J Gastroenterol. 2002. 40: 1-14.